Abstract:
Background: HIV/AIDS is a global pandemic which is caused by the virus called human
immunodeficiency virus (HIV). The epidemic was firstly recognized in the year 1980. In 2016, an
estimated 36.7 million people were living with human immunodeficiency virus (HIV) or acquired
immunodeficiency syndrome (AIDS). HIV/AIDS is a disease, which has health, economic and
social consequences. The end impact of all these consequences is economic impact.
Objective: To estimate the economic cost of HIV/AIDS and associated factors among
individuals on ART follow up and their family in Oromia Special Zone Surrounding Finfine,
Ethiopia in ,2018
Methods: This study was conducted in Oromia Special Zone Surrounding Finfine. Facility based
cross-sectional study design was employed to select sample of 350 adult PLWHA on ART follow
up using single population mean formula. One public primary Hospital and 4 public Health
Centers were randomly selected by random sampling technique using lottery method.
Interviewer administered questionnaires were used to get information on the direct and indirect
costs related to HIV/AIDS care and treatment. Descriptive statistics such as mean, standard
deviation, median and percentage were calculated to describe some parts of the results. The
association between the independent and dependent variable were assessed by using multi linear
regression model in Statistical Package for Social Science (SPSS) version 23.
Results: The mean total cost of HIV/AIDS among individual on ART follow up was US$10.5 per
month, the mean total direct cost was US$ 6.35 per month and total mean indirect cost was US$
5.53) per month. Distance, Supplementary food, opportunistic infection and patient accompanied
had statistically significant association with total cost of HIV/AIDs among these individuals at pvalue less than 0.05.
Conclusion and recommendation: According to this study finding individuals on ART follow up
exposed to a significant total cost that comes from direct medical cost, non medical cost and
indirect costs.